Ledger.Open graph →

SEC Form D · filed September 9, 2022

Arsenal Biosciences, Inc

Offering

$230.8M

Sold

$220.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Beth Seidenberg · South San Francisco, CADirector Matthew Fust · South San Francisco, CADirector Sean Parker · South San Francisco, CADirector Margaret Nibbi · South San Francisco, CAExec Valentin Barsan · South San Francisco, CADirector Kenneth Drazan · South San Francisco, CAExec · Director Brook Byers · South San Francisco, CADirector Edward A. Schafer · Old Bethpage, NYDirector Jeffrey F. O'Donnell Sr · Malvern, PADirector Salvatore C. Zizza · Old Bethpage, NYExec Mark A. Smith · Old Bethpage, NYDirector Jon C. Northrop · Old Bethpage, NYDirector Jeffrey F. O'Donnell Jr · Malvern, PADirector William A. Rupp · Old Bethpage, NYExec · Director Neeraj B. Hablani · New York, NYDirector Raghav Mecheri · New York, NYExec · Director James B. Bollas · New York, NYDirector Alex B. Hartz · New York, NYExec Andrew J. Secrist · Salt Lake City, UTDirector Sarah Hunt · Purchase, NYDirector Jennifer L. Norris · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗